Next Generation News and Research

RSS

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Watson Pharmaceuticals, Inc. and Antares Pharma, Inc. today announced an exclusive licensing agreement for Watson to commercialize Antares' topical oxybutynin gel product in the U.S. and Canada.

11 Jul 2011

NewYork-Presbyterian Hospital offers two new treatment options for cancer patients

NewYork-Presbyterian Hospital has two new treatment options for patients with brain tumors and other cancers -- a next-generation radiosurgical Gamma Knife and linear accelerator.

From Elekta 11 Jul 2011

Isogenica opens new automation facility

Isogenica Ltd today announced the opening of a new automation facility at their current location, Chesterford Research Park.

11 Jul 2011

First dog enters ADXS-HER2 dose-ranging study in canine osteosarcoma

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announces that the first dog has entered a dose-ranging in canine osteosarcoma at the University of Pennsylvania School of Veterinary Medicine.

8 Jul 2011

Extensive genomic, transcriptional diversity identified through massively parallel DNA and RNA sequencing

In a paper published in the online edition of Nature Genetics on July 3, 2011, sequencing specialists at Axeq Technologies, and scientists from Macrogen Inc., Genomic Medicine Institute at Seoul National University, Psoma Therapeutics Inc., Brigham and Women's Hospital and Harvard Medical School reported the discovery of a wide range of novel genetic variants based on the deep sequencing of 18 genomes and 17 transcriptomes of unrelated Korean individuals.

8 Jul 2011

GE Healthcare's Magnetic Resonance Imaging receives 2011 IDEA awards

GE Healthcare, a unit of General Electric Company, today announced it received several Silver Awards from the 2011 International Design Excellence Awards for Magnetic Resonance Imaging by the Industrial Designers Society of America.

8 Jul 2011

Oxford Gene Technology sequencing workshop attracts over 130 delegates

Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, recently announced details of its new targeted sequencing service as part of a workshop at the European Society of Human Genetics Conference (ESHG 2011) in Amsterdam, The Netherlands.

From Oxford Gene Technology 7 Jul 2011

Review of non-smoker patient with lung cancer to be presented at IASLC conference

A first-of-its-kind study of a patient with lung cancer who never smoked will be presented today by TGen and the Virginia G. Piper Cancer Center at Scottsdale Healthcare at the 14th World Conference on Lung Cancer, July 3-7 in Amsterdam.

6 Jul 2011

New biological insights into fat tissue

For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone has been in the spotlight for its possible link to increased cardiovascular events, but it also seems to come with unexplained vascular benefits and an unwelcome tendency for weight gain.

6 Jul 2011

DHS S&T develops personal dosimeter to measure radiation exposure

No matter how many plastic cards currently crowd your wallet, one day you may wish to make room for one more. The Department of Homeland Security's Science and Technology Directorate has developed a miniaturized version of a dosimeter, a portable device used for measuring exposure to ionizing radiation, which can provide life-saving early detection in the unlikely event of a nuclear accident or dirty bomb.

2 Jul 2011

Autism Speaks Weatherstone fellows publish new mouse model findings in Cell journal

Autism Speaks Weatherstone Pre-Doctoral Fellows M. Ali Bangash, a 2009 fellow, and Mehreen Kouser, a 2010 fellow, recently published new findings in the journal Cell that shed light on the biology of autism.

1 Jul 2011

Genetic mutations in abnormal bone marrow can predict mortality of MDS patients

For patients with myelodysplastic syndromes (MDS), choosing the appropriate treatment depends heavily on the prognosis. Those patients at the highest risk of dying from their disease are typically offered the most aggressive therapies, while patients at lower risk could live several years with MDS, needing only supportive care or other relatively side-effect free treatments.

1 Jul 2011

Lantheus commences flurpiridaz F 18 PET MPI Phase 3 trial for detection of coronary artery disease

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of the first of two Phase 3 clinical trials to assess myocardial perfusion using Positron Emission Tomography (PET) imaging with flurpiridaz F 18 in patients with suspected or known coronary artery disease (CAD).

1 Jul 2011

FDA grants Advaxis pre-IND meeting for Advaxis-PSA immunotherapy for prostate cancer

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on August 10, 2011 to discuss the CMC, pharmacology, toxicology, and clinical plans for Advaxis PSA, its construct to fight prostate cancer.

1 Jul 2011

KCI receives reimbursement status for V.A.C.Via Negative Pressure Wound Therapy System

Kinetic Concepts, Inc. today announced that its groundbreaking V.A.C.Via Negative Pressure Wound Therapy System has been granted reimbursement status and will be listed on the U.K. Drug Tariff beginning August 1, 2011.

30 Jun 2011

Harvard University, UCB enter innovative research collaboration

UCB and Harvard University officially launched their innovative Research Alliance during a signing ceremony that took place in Boston last night in the presence of his Royal Highness Prince Philippe of Belgium.

30 Jun 2011

MEDICREA launches GRANVIA-C pre-IDE pilot trial for treatment of spinal pathologies

The MEDICREA Group, listed on Alternext by NYSE Euronext Paris, a medical device company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, reaffirmed its ambitious marketing schedule today for GRANVIA-C, its next-generation cervical disc prosthesis, and also announced the launch of a pre-IDE pilot trial with a view to initiating the approval process in the United States.

30 Jun 2011

Exciton enters distribution agreement with Marathon Medical

Exciton Technologies Inc. today announced the Company has signed a distribution agreement with Marathon Medical, adding them to the existing Federal Supply Schedule (FSS) contract, administered by the Department of Veterans Affairs on behalf of the U.S. General Services Administration (GSA), effective July 1st.

29 Jun 2011

Acetylon to advance ACY-1215 drug candidate with $27M Series B Preferred equity investment round of financing

Acetylon Pharmaceuticals, Inc. announced today that it has completed a $27 million Series B Preferred equity investment round of financing.

29 Jun 2011

Some adult survivors of childhood cancer are at risk for multiple cancers

The largest study yet of adult childhood cancer survivors found that the first cancer is just the beginning of a lifelong battle against different forms of the disease for about 10 percent of these survivors.

29 Jun 2011

Next Generation News and Research

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

NewYork-Presbyterian Hospital offers two new treatment options for cancer patients

Isogenica opens new automation facility

First dog enters ADXS-HER2 dose-ranging study in canine osteosarcoma

Extensive genomic, transcriptional diversity identified through massively parallel DNA and RNA sequencing

GE Healthcare's Magnetic Resonance Imaging receives 2011 IDEA awards

Oxford Gene Technology sequencing workshop attracts over 130 delegates

Review of non-smoker patient with lung cancer to be presented at IASLC conference

New biological insights into fat tissue

DHS S&T develops personal dosimeter to measure radiation exposure

Autism Speaks Weatherstone fellows publish new mouse model findings in Cell journal

Genetic mutations in abnormal bone marrow can predict mortality of MDS patients

Lantheus commences flurpiridaz F 18 PET MPI Phase 3 trial for detection of coronary artery disease

FDA grants Advaxis pre-IND meeting for Advaxis-PSA immunotherapy for prostate cancer

KCI receives reimbursement status for V.A.C.Via Negative Pressure Wound Therapy System

Harvard University, UCB enter innovative research collaboration

MEDICREA launches GRANVIA-C pre-IDE pilot trial for treatment of spinal pathologies

Exciton enters distribution agreement with Marathon Medical

Acetylon to advance ACY-1215 drug candidate with $27M Series B Preferred equity investment round of financing

Some adult survivors of childhood cancer are at risk for multiple cancers

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News